Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed

February 28, 2023

https://www.globenewswire.com/news-release/2023/02/28/2617240/0/en/Sale-of-Flow-Cytometry-and-Imaging-Business-From-DiaSorin-to-Cytek-Biosciences-Completed.html

SALUGGIA, Italy, and FREMONT, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) — DiaSorin (FTSE MIB: DIA) and Cytek Biosciences, Inc. (Nasdaq:CTKB) today announced that Luminex Corporation, a wholly owned subsidiary of DiaSorin, has completed the sale of substantially all of its assets related to the Flow Cytometry & Imaging (FCI) business unit to Cytek for approximately USD 46.5 million.

Read more at globenewswire.com

Related news for (CTKB)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.